Oppenheimer Reiterates Outperform on Kala Bio, Maintains $15 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Francois Brisebois has reiterated an Outperform rating on Kala Bio (NASDAQ:KALA) and maintained a price target of $15.

August 19, 2024 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer has reiterated its Outperform rating for Kala Bio, maintaining a $15 price target, indicating confidence in the company's future performance.
The reiteration of an Outperform rating and a maintained price target of $15 by Oppenheimer suggests positive sentiment and confidence in Kala Bio's future performance, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100